IP Library Patent Application 11556149
Patent Application
App. No. 11/556,149

Methods of Light Activated Release of Ligands from Endosomes

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/556,149
Abstract

Methods for delivering ligands to a cell by using light to activate fluorescent ligands causing their release from endosomes. The instant methods thus increasing the efficiency of ligands, e.g. in vitro or at localized sites within a subject. The invention provides for the release of ligands by shining a light source on a cell to promote release of ligands into the cell where they can effect their function.

Claims (34)

1 . A method of delivering a ligand to a cell comprising:

a) contacting a cell with a ligand and a fluorophore; and

b) illuminating the cell with a light that activates the fluorophore such that the ligand is delivered to the cell.

2 . The method of claim 1 , wherein the ligand is an oligonucleotide.

3 . The method of claim 1 , wherein the ligand is peptide.

4 . The method of claim 1 , wherein ligand is a fluorescent virus.

5 . The method of claim 1 , wherein the ligand is a morpholino oligonucleotide.

6 . The method of claim 1 , wherein the ligand is a sense oligonucleotide.

7 . The method of claim 1 , wherein the ligand is an antisense oligonucleotide.

8 . The method of claim 1 , wherein the ligand enters an endosome of the cell during step (a).

9 . The method of claim 8 , wherein the illuminating of step (b) causes the endosome containing the ligand to release the ligand.

10 . The method of claim 1 , wherein the light has a wavelength of about 10 to about 380 nm.

11 . The method of claim 1 , wherein the light has a wavelength of about 380 to about 500 nm.

12 . The method of claim 1 , wherein the cells are illuminated for less than about 2 minutes.

13 . The method of claim 1 , wherein the cells are illuminated for less than about 1 minute.

14 . The method of claim 1 , wherein the light of step (b) is produced from a flexible endoscopic light source.

15 . The method of claim 1 , wherein the fluorophore and the ligand are linked via a covalent linkage.

16 . The method of claim 1 , wherein the fluorophore is a fluorescein fluorophore.

17 . The method of claim 1 , wherein the fluorophore and the ligand contacted with the cell simultaneously.

18 - 32 . (canceled)

33 . The method of claim 17 , wherein the localized site is inside the colon of the subject.

34 . The method of claim 17 , wherein the localized site is on the skin of the subject.

35 . The method of claim 17 , wherein the localized site is a tumor.

36 . A method of modulating protein production at a localized site in a subject comprising:

a) exposing a group of cells of the subject to a ligand and a fluorophore; and

b) illuminating the cells at a localized site in the subject with light that activates the fluorophore such that protein production at a localized site in the subject is modulated.

37 . The method of claim 36 , wherein protein production is enhanced.

38 . The method of claim 37 , wherein protein production is inhibited.

39 . A method of modulating protein activity at a localized site in a subject comprising:

a) exposing a group of cells of the subject to a ligand and a fluorophore; and

b) illuminating the cells at a localized site in the subject with light such that the fluorophore is activated and protein activity at a localized site in a subject is modulated.

40 . The method of claim 39 , wherein protein activity is enhanced.

41 . The method of claim 39 , wherein protein activity is inhibited.

42 . (canceled)

Assignments (2)
LIEN RELEASE Recorded Apr 9, 2013
From: BANK OF AMERICA, N.A.
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 030182/0461 →
SECURITY AGREEMENT Recorded Dec 5, 2008
From: LIFE TECHNOLOGIES CORPORATION
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 021975/0467 →